Health Secretary Robert F. Kennedy Jr. supports expanding access, despite warnings from FDA scientists about insufficient safety and effectiveness data.
An FDA advisory panel recommended allowing six of seven peptides under review, despite opposition from agency scientists. The plan has not been finalized.
Source: WaPo
Post #100103
4.18K
The Trump administration is considering temporarily allowing compounding pharmacies to sell certain previously restricted peptides while the FDA develops new regulations.
- 🤬 31
- ❤ 7
- 🤣 2
- 🤔 1
- 🖕 1